Appearance White powder
Purity (HPLC) ≥95.0%
Simple impurity≤1.0%
Acetate content 5.0%~12.0%
Moisture content≤10.0%
Peptide content ≥ 80.0%
Packaging and Shipping:
Low temperature, vacuum packaging, accurate to milligrams upon request.
Product Description:
Enfuvirtide acetate was approved by the US FDA in 2003, and it is used in combination with other anti-HIV drugs in the treatment of HIV infection. Enfuvirtide is a new type of antiretroviral drug, and it has been the pioneer of anti-AIDS treatment drugs in the past seven years. Enfuvirtide mimics the HR2 domain and is a 36 amino acid polypeptide derived from HIV-1 gp41 protein. It is a selective and effective inhibitor of HIV-1 fusion and infection. It can bind to the HR1 trimer helix and prevent HR1- Formation of HR2 six-helix bundles, thus preventing fusion of viral particles with host cells.
Q1. What is your terms of packing?
A: Generally, we pack our goods in neutral white boxes and brown cartons. If you have legally registered patent,
we can pack the goods in your branded boxes after getting your authorization letters.
Q2. What is your terms of payment?
A: T/T ,Western Union, Bitcoin, PayPal
If OEM,T/T 30% as deposit, and 70% before delivery. We'll show you the photos of the products and packages
before you pay the balance.
Q3. What is your terms of delivery?
A: EXW, FOB, CFR, CIF, DDU.
Q4. How about your delivery time?
A: To EU countries, 7-12 days
To the US, 5-15 days
To Asian country,5-10 days
Q5. Can you make labels and boxes?
A: Yes
Q6. What is your sample policy?
A: We can supply the sample if we have ready parts in stock, but the customers have to pay the sample cost and
the courier cost.
Q7. Do you test all your goods before delivery?
A: Yes, we have 100% test before delivery
Q8: How do you make our business long-term and good relationship?
A:1. We keep good quality and competitive price to ensure our customers benefit ;
2. We respect every customer as our friend and we sincerely do business and make friends with them,
no matter where they come from.